BTRC and breast cancer: In HER2-positive breast cancer, the new β-TrCP-343aa isomer encoded by circular RNA (circ-β-TrCP) binds competitively to NRF2, blocking its ubiquitination and degradation, resulting in over-activation of NRF2.